Copyright: ©Author(s) 2026.
World J Clin Oncol. Oct 24, 2026; 17(10): 123273
Published online Oct 24, 2026. doi: 10.5306/wjco.123273
Published online Oct 24, 2026. doi: 10.5306/wjco.123273
Figure 5 Network meta-analysis of conservative treatments for inhibition of subsequent endometrial cancer in patients with atypical polypoid adenomyoma.
A: Network structure of treatments; B: Rankings of interventions based on their ability to suppress endometrial cancer as indicated by surface under the cumulative ranking curve analysis; C: Forest plot of preventing endometrial cancer for treatments compared to transcervical resection of polyps; D: Net league diagram comparing the effectiveness of any two treatments. TCRP: Transcervical resection of polyps; LNG-IUS: Levonorgestrel-releasing intrauterine system; COC: Combined oral contraceptive; PT: Progesterone therapy; TCRE: Transcervical resection of endometrium; HDP: High-dose progestin; MT: Hormone maintenance therapy; PWH: Polyp resection without hysteroscopy; GnRH-a: Gonadotrophin-releasing hormone agonist; 95%CI: 95% confidence interval.
- Citation: Huang JZ, Liu X, Deng YW, Wei CN, Tang SL, Zhi ZF. Endometrial polypoid adenomyoma outcomes and fertility-sparing treatments efficacy for atypical type: A systematic review and network meta-analysis. World J Clin Oncol 2026; 17(10): 123273
- URL: https://www.wjgnet.com/2218-4333/full/v17/i10/123273.htm
- DOI: https://dx.doi.org/10.5306/wjco.123273